Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test Strip

Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for 
Its Popular GenStrip Test Strip 
Recent Court Rulings and Changes in Medicare Reimbursement Practice
Enhancing GenStrip Sales 
LOS ANGELES, CA -- (Marketwired) -- 10/01/13 --  Decision Diagnostics
Corp. (OTCBB: DECN), the exclusive worldwide sales, service and
regulatory processes agent for the popular Shasta GenStrip(TM), the
unique Green Glucose Test Strip, specifically designed to work with
the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose
testing meters, today announced that its Pharma Tech Solutions
subsidiary has scheduled for shipments large box quantities of
GenStrip for immediate delivery to its distributors as partial
fulfillment of current sales orders. 
Keith Berman, Principal Executive Officer of Decision Diagnostics,
commented, "Beginning in July 2013 Medicare changed its reimbursement
practice. These changes have proven to be an unexpected boom for our
business."  
DECN is a leading provider of prescription and non-prescription
diagnostics, home testing products for the chronically ill and a
premier developer of revolutionary cell phone centric e-health
products and technologies. DECN's FDA cleared Shasta GenStrip(TM)
product was first introduced to the market in late 2012 as a lower
cost (50%) alternative for user/owners of Johnson and Johnson
LifeScan OneTouch(R) Ultra(R), Ultra2(R) and Ultra Mini(R) glucose
meters. 
Mr. Berman concluded, "In August and September 2013 we received
several favorable court rulings and the analyses of these rulings
from the media added to the positive outlook for GenStrip sales. The
product is being looked at by all of the large retailers and is
already a hit with the independent distributors. Initially we will
take delivery of over 60,000 boxes of GenStrip to begin fulfillment
of existing orders."  
The company also reminds shareholders and all interested parties that
it continues to air its new commercial video titled "GenStrip: A
Patchwork of Life." The company plans on releasing a media schedule
in the coming days. In the meantime, the extremely popular video is
available for viewing at: http://shastagenstrip.com/shasta_ad.html or
http://youtu.be/zzBuHxb-rlM.   
Forward-Looking Statements:  
This release contains forward-looking statements about our business
or financial condition that reflect our assumptions and beliefs based
on information currently available. We can give no assurance that the
expectations indicated by such forward-looking statements will be
realized. There may be other risks and circumstances that we are
unable to predict. When used in this release, words such as
"believes," "expects," "forecasts," "intends," "projects," "plans,"
"anticipates," "estimates," "will" and similar expressions are
intended to identify forward-looking statements, although there may
be certain statements not accompanied by such expressions.  
For further information about Shasta GenStrip, please visit the
company's Web Sites: http://www.decisiondiagnostics.com or
http://www.shastagenstrip.com.  
GenStrip(TM) test strips are a product of Shasta Technologies, LLC
and are not manufactured, distributed, endorsed, or approved by nor
associated with LifeScan(R), Inc. a Johnson & Johnson(R) Company,
manufacturers and distributors of the OneTouch(R) Ultra(R) Family of
Meters and OneTouch(R) Ultra(R) test strips.  
Contact: 
Decision Diagnostics Corp.
Keith Berman
(805) 446-2973
info@decisiondiagnostics.com 
 
 
Press spacebar to pause and continue. Press esc to stop.